In fact, HCaRG levels are significantly decreased in tumors of brain, kidney and liver compared to normal adjacent tissues [2] and rosiglitazone suppressed the growth of gastric cancer by up-regulating HCaRG [58]. This evidence concerns the gene COMMD5 and gastric cancer.